2.A Case of T-cell Primary Pulmonary LymphomaDiagnosed by TCRgamma gene rearrangement.
Young Mee CHOI ; Seung Joon KIM ; Soon Seog KWON ; Young Kyoon KIM ; Kwan Hyoung KIM ; Hwa Sik MOON ; Sung Hak PARK ; Jeong Sup SONG
Tuberculosis and Respiratory Diseases 1996;43(6):1001-1007
No abstract available.
Gene Rearrangement*
;
Lung
;
Lymphoma
;
Polymerase Chain Reaction
;
T-Lymphocytes*
3.Gene rearrangement of specific exons of immunoglobulin heavy chain joining region in B- lymphoid leukemias.
Chan Jeoung PARK ; Hyun Chan CHO ; John UHMACHER
Korean Journal of Hematology 1993;28(2):307-312
No abstract available.
Exons*
;
Gene Rearrangement*
;
Immunoglobulin Heavy Chains*
;
Immunoglobulins*
;
Leukemia, Lymphoid*
5.Immunoglobulin and T-cell receptor gene rearrangement analysis in malignant lymphoid neoplasms.
Chan Kum PARK ; Chul Woo KIM ; In Soon KIM ; Jung Dal LEE
Journal of Korean Medical Science 1994;9(5):362-368
Gene rearrangement analysis using Southern-blot hybridization technique is a standard method for evaluating clonal receptor gene rearrangement. Both clonality and lineage can be identified in lymphoid neoplasms by the demonstration of one or more rearranged antigen receptor genes of the immunoglobulin supergene family-immunoglobulin and T-cell receptor genes. To evaluate the diagnostic applicability of antigen receptor gene rearrangements in the diagnosis of malignant lymphomas and leukemias, the authors performed a gene rearrangement analysis of 54 cases by southern blot hybridization technique. One or two clonally rearranged bands were detected in the malignant lymphomas and in the lymphoblastic leukemias with a false-negative rate of 13.8%. No clonal, rearranged band was detected in benign reactive hyperplasias, carcinomas or non-lymphocytic leukemias. Rearrangement analysis could resolve the lineage, clonality and stage of differentiation of malignant lymphoid neoplasms.
Gene Rearrangement
;
*Gene Rearrangement, T-Lymphocyte
;
*Genes, Immunoglobulin
;
Human
;
Leukemia/*genetics/immunology
;
Lymphoma/*genetics/immunology
;
Support, Non-U.S. Gov't
7.Diagnostic role of BIOMED-2 multiplex polymerase chain reaction for antigen receptor genes rearrangement in lymphoproliferative disorders.
Yan-Ling LIU ; Mei HUANG ; Deng-Ju LI ; Yi XIAO ; Yi TANG ; Fan-Kai MENG ; Jin-Niu DENG ; Han-Ying SUN ; Wen-Li LIU ; Jian-Feng ZHOU
Chinese Journal of Hematology 2009;30(4):251-254
OBJECTIVETo establish a sensitive and effective method for detection of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangement,and to explore its role in diagnosis and differential diagnosis of lymphoproliferative disorders.
METHODSFifty-eight lymphoid tissue samples from 54 patients with lymphoproliferations were evaluated by the novel BIOMED-2 multiplex polymerase chain reaction (PCR) for antigen receptor genes rearrangement.
RESULTSMultiplex PCR demonstrated monoclonal Ig/TCR gene rearrangements in 22 of 25 (88.0%) B-cell malignancies and 8 of 15 (53.3%) T-cell malignancies. Among 17 benign lymphoproliferations confirmed histopathologically, polyclonal rearrangements were detected in 14 cases (82.4%). In total, the clonality analysis and the final clinico-histopathological diagnosis were concordant in 77.2%. Combination detection of Iglambda and TCR delta gene rearrangements did not increase the detection rate of monoclonal rearrangement of Ig/TCR, but might help to the detection of Iglambda+ or TCR delta+ lymphomas.
CONCLUSIONThe novel BIOMED-2 multiplex PCR strategy is a rapid, reliable and sensitive approach to detecting clonality in suspected lymphoproliferations, especially in atypical cases.
Female ; Gene Rearrangement, B-Lymphocyte, Light Chain ; Gene Rearrangement, T-Lymphocyte ; Humans ; Lymphoproliferative Disorders ; diagnosis ; genetics ; Male ; Polymerase Chain Reaction ; methods ; Sensitivity and Specificity
8.A case of biphenotypic acute leukemia with expression of the AML1-ETO gene rearrangement.
Ju Hee SEO ; Hye Won LEE ; Ju Eun LIM ; Joo Won CHUNG ; Jong Rak CHOI ; Woo Ick YANG ; Yoo Hong MIN
Korean Journal of Medicine 2009;76(5):617-621
Biphenotypic acute leukemia (BAL) is a subtype of acute leukemia that expresses two different immunophenotypic lineages, most commonly myeloid and either B- or T-lymphoid lineages. This entity has been defined by a scoring system proposed by the European Group for the Immunological Characterization of Leukemias (EGIL). The prognosis of BAL is regarded as being worse than either acute lymphoid or myeloid leukemia that does not show lineage ambiguity. However, a treatment strategy for BAL has not yet been established. We experienced a case of BAL with the t(8;21) translocation, a favorable cytogenetic rearrangement in acute myeloid leukemia (AML). The patient was successfully treated with cytarabine and anthracycline for induction and consolidation. The quantitative value of the AML1-ETO gene decreased after achieving complete hematologic remission. Thus, the AML1-ETO gene rearrangement in BAL may be associated with an acceptable response to the treatment strategy for AML.
Cytarabine
;
Cytogenetics
;
Gene Rearrangement
;
Humans
;
Leukemia
;
Leukemia, Biphenotypic, Acute
;
Leukemia, Myeloid
;
Leukemia, Myeloid, Acute
;
Prognosis
9.Significance of BIOMED-2 standardized IG/TCR gene rearrangement detection in paraffin-embedded section in lymphoma diagnosis.
Xiaofei AI ; Qianqian FU ; Jun WANG ; Yingchun ZHENG ; Cong HAN ; Qinghua LI ; Qi SUN ; Kun RU
Chinese Journal of Hematology 2014;35(6):495-498
OBJECTIVETo explore the feasibility of detecting lymphoma with the application of BIOMED-2 standardized immunoglobulin/T cell receptor (IG/TCR) gene rearrangement system in formalin fixed paraffin-embedded (FFPE) tissue samples, and to discuss the relationship between the longest amplification fragment of extracted DNA and positive detection rate of different IGH V-J primers.
METHODSDNA was extracted from 50 cases of FFPE tissue samples. Multiplex-PCR amplifications were performed and then the IG/TCR gene rearrangements were analyzed using BIOMED-2 standardized clonality analysis system.
RESULTS(1)When the DNA concentration was diluted to 50-100 ng/μl from 100-500 ng/μl, the proportion of the longest amplification fragment (300-400 bp) of DNA was improved from 10.0% to 90.0% in 30 cases of diffuse large B cell lymphoma (DLBCL) wax roll samples (P<0.01). The positive rate of IGH+IGK was increased from 46.7% to 83.3%, the difference was statistically significant (P=0.006). The lengths of the longest amplification fragments of DNA were all longer than 300 bp in the paraffin section samples of DLBCL. The positive rate of IGH+IGK of these samples was 96.7%. The difference of the positive rate of IGH+IGK between the wax roll samples and the paraffin section samples had no statistical significance (P=0.195). (2)When the concentration of DNA was high, most of the longest amplification fragments of extracted DNA were 100 bp or 200 bp, and the detection rate of short fragment IGH FR3 was more stable than that of long fragment IGH FR1. (3)The clonality analysis of TCRG+TCRB in all 13 cases of peripheral T cell lymphoma samples showed positive results, while no positive IG/TCR clones were found in 7 cases of reactive lymphoid tissue hyperplasia in control group.
CONCLUSIONDilution of DNA is the only method to improve not only the proportion of longest fragment amplification but also the detection rate of clonality. The detection rate of IGH FR3 would not be affected by the concentration of DNA. The application of BIOMED-2 standardized IG/TCR gene rearrangement system in FFPE tissue samples plays an important role in the lymphoma diagnosis.
Gene Rearrangement, T-Lymphocyte ; Humans ; Lymphoma ; diagnosis ; genetics ; Paraffin Embedding ; V(D)J Recombination
10.Diagnostic Usefulness of Genomic Breakpoint Analysis of Various Gene Rearrangements in Acute Leukemias: A Perspective of Long Distance- or Long Distance Inverse-PCR-based Approaches.
John Jeongseok YANG ; Rolf MARSCHALEK ; Claus MEYER ; Tae Sung PARK
Annals of Laboratory Medicine 2012;32(4):316-318
No abstract available.
Acute Disease
;
*Gene Rearrangement
;
Genome, Human
;
Humans
;
Leukemia/*diagnosis/genetics
;
Polymerase Chain Reaction/*methods
;
Translocation, Genetic